Implantable cardiovascular sensors and computers: interventional heart failure strategies.
Despite evidence-based medical and pharmacologic advances the management of heart failure remains challenging, whether in the ambulatory setting where daily weight monitoring has failed, or in the inpatient setting where readmission rates and morbidity remains high. There is an urgent need to develop strategies to reduce hospitalizations and readmission rates for heart failure in general. There may be a shift in the paradigm with respect to the treatment of heart failure, which may usher in an era of invasive heart failure therapies and specialists. Experimental invasive devices and monitors have the potential to be game-changing therapies, and cardiac resynchronization therapy has evolved beyond just resynchronization and has the potential to provide important real-time hemodynamic feedback.
Division of Cardiovascular Medicine, Davis Heart and Lung Research Institute, Wexner Medical Center at The Ohio State University, 473 W. 12th Avenue, Suite 200, Columbus, OH 43210, USA. sakima.smith@osumc.edu
Sakima A
SA
Smith
William T
WT
Abraham
D058406:Cardiac Resynchronization Therapy / Q000379:methods; D058409:Cardiac Resynchronization Therapy Devices; D002307:Cardiography, Impedance / Q000295:instrumentation / Q000379:methods; D017147:Defibrillators, Implantable; D004599:Electric Stimulation Therapy / Q000295:instrumentation / Q000379:methods; D006333:Heart Failure / Q000175:diagnosis* / Q000628:therapy; D006439:Hemodynamics; D006801:Humans; D018670:Monitoring, Ambulatory / Q000295:instrumentation / Q000379:methods*; D019736:Prostheses and Implants